Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06682312 · ClinicalTrials.gov registry record
Philips Non-Invasive Blood Pressure Validation Study
A clinical trial, sponsored by Philips Clinical & Medical Affairs Global.
- Terminated
- Registry status
- 89
- Enrollment target
NCT06682312 is a clinical trial that was terminated before completion, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 89 participants.
The verdict
NCT06682312 was terminated before completion, sponsored by Philips Clinical & Medical Affairs Global.
- TERMINATED
- Registry status
- 89 participants
- Enrollment target
Study Summary
The purpose of this study is to provide supporting documentation of the blood pressure performance for the Philips EarlyVue VS30 monitor on the intended adult and pediatric population. The same arm sequential method with dual observer auscultation will be used to collect data.
Interventions
- DEVICE Non-invasive blood pressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2024-10-14 |
| Est. Completion | 2024-10-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06682312
The ClinicalTrials.gov registry entry for NCT06682312 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Clinical & Medical Affairs Global, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-invasive blood pressure is the first listed.
NCT06682312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06682312 about?
NCT06682312 is a clinical study titled "Philips Non-Invasive Blood Pressure Validation Study". The purpose of this study is to provide supporting documentation of the blood pressure performance for the Philips EarlyVue VS30 monitor on the intended adult and pediatric population. The same arm sequential method with dual observer auscultation will be used to collect data.
What is the current status of trial NCT06682312?
This trial is currently terminated. The enrollment target is 89 participants. The study started on 2024-10-14. Estimated completion is 2024-10-23.
What interventions are being tested in trial NCT06682312?
The interventions under investigation include: Non-invasive blood pressure (DEVICE).
Who is sponsoring clinical trial NCT06682312?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.